| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9625 |
| Human Intestinal Absorption | HIA+ | 1.0000 |
| Caco-2 Permeability | Caco2+ | 0.8768 |
| P-glycoprotein Substrate | Substrate | 0.6612 |
| P-glycoprotein Inhibitor | Inhibitor | 0.6044 |
| Non-inhibitor | 0.7274 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.7803 |
| Distribution |
| Subcellular localization | Mitochondria | 0.6661 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.7922 |
| CYP450 2D6 Substrate | Non-substrate | 0.8921 |
| CYP450 3A4 Substrate | Substrate | 0.7862 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.8359 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.8720 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9576 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.7319 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.8005 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8740 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.8860 |
| Non-inhibitor | 0.6753 |
| AMES Toxicity | Non AMES toxic | 0.9408 |
| Carcinogens | Non-carcinogens | 0.9302 |
| Fish Toxicity | High FHMT | 0.9704 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9861 |
| Honey Bee Toxicity | High HBT | 0.8585 |
| Biodegradation | Not ready biodegradable | 0.9493 |
| Acute Oral Toxicity | III | 0.7922 |
| Carcinogenicity (Three-class) | Warning | 0.4667 |